Approved treatments
for IGG

Uplizna

Uplizna (inebilizumab) is a therapy approved in the U.S. for adults with IgG4-RD. Administered directly into the bloodstream every six months after two initial doses, it works by killing B-cells, a type of immune cell known to contribute to the disease.

Learn more

Glucocorticoids

Glucocorticoids, a type of anti-inflammatory and immunosuppressive medication, remains the first-line treatment for IgG4-RD.

Learn more